- Home
- EPOW vs AIFF Comparison
EPOW vs AIFF Comparison
Compare EPOW & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- AIFF
- Stock Information
- Founded
- EPOW 2014
- AIFF 2006
- Country
- EPOW China
- AIFF Canada
- Employees
- EPOW N/A
- AIFF N/A
- Industry
- EPOW Business Services
- AIFF
- Sector
- EPOW Consumer Discretionary
- AIFF
- Exchange
- EPOW Nasdaq
- AIFF NYSE
- Market Cap
- EPOW 23.9M
- AIFF 24.9M
- IPO Year
- EPOW 2021
- AIFF N/A
- Fundamental
- Price
- EPOW $0.85
- AIFF $2.93
- Analyst Decision
- EPOW
- AIFF
- Analyst Count
- EPOW 0
- AIFF 0
- Target Price
- EPOW N/A
- AIFF N/A
- AVG Volume (30 Days)
- EPOW 17.5K
- AIFF 65.7K
- Earning Date
- EPOW 11-29-2024
- AIFF 11-14-2024
- Dividend Yield
- EPOW N/A
- AIFF N/A
- EPS Growth
- EPOW N/A
- AIFF N/A
- EPS
- EPOW N/A
- AIFF N/A
- Revenue
- EPOW $45,050,405.00
- AIFF $74,000.00
- Revenue This Year
- EPOW N/A
- AIFF N/A
- Revenue Next Year
- EPOW N/A
- AIFF N/A
- P/E Ratio
- EPOW N/A
- AIFF N/A
- Revenue Growth
- EPOW 18.16
- AIFF N/A
- 52 Week Low
- EPOW $0.53
- AIFF $2.74
- 52 Week High
- EPOW $1.36
- AIFF $15.90
- Technical
- Relative Strength Index (RSI)
- EPOW 37.72
- AIFF 42.66
- Support Level
- EPOW $0.86
- AIFF $2.92
- Resistance Level
- EPOW $0.92
- AIFF $3.36
- Average True Range (ATR)
- EPOW 0.07
- AIFF 0.34
- MACD
- EPOW -0.01
- AIFF -0.02
- Stochastic Oscillator
- EPOW 0.05
- AIFF 9.52
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is into the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.